Showing results (1-10 of 407) with videos related to
Sort By:
Pageof 41
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 30, 2002
C-reactive protein and cardiovascular disease: a review of risk prediction and interventionsSarah de Ferranti, Nader RifaiCurrent Opinion in Lipidology|August 2, 2002
Inflammatory markers and coronary heart diseaseNader Rifai, Paul M RidkerScandinavian Journal of Clinical and Laboratory Investigation. Supplementum|June 3, 2010
What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schemaAdam S Ptolemy, Nader RifaiClinica Chimica Acta; International Journal of Clinical Chemistry|July 6, 2004
Quality specifications and the assessment of the biochemical risk of atherosclerosisNader Rifai, G Russell WarnickClinical Chemistry|July 26, 2003
Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessmentThomas B Ledue, Nader RifaiCardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 16, 2007
C-reactive protein: a nontraditional serum marker of cardiovascular riskSarah D de Ferranti, Nader RifaiDiabetes|September 28, 2007
Interleukin-6 receptor gene variations, plasma interleukin-6 levels, and type 2 diabetes in U.S. WomenLu Qi, Nader Rifai, Frank B HuCritical Reviews in Clinical Laboratory Sciences|October 19, 2002
High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessmentLaura R Benzaquen, Harry Yu, Nader RifaiClinical Chemistry|January 24, 2002
Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculationMatthias Nauck, G Russell Warnick, Nader RifaiDiabetes|October 15, 2008
Interleukin-6 receptor gene, plasma C-reactive protein, and diabetes risk in womenLu Qi, Nader Rifai, Frank B HuPageof 41